JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

The Journal of Nuclear Medicine Vol. 15 No. 3 210-212
© 1974 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hisada, K.
Right arrow Articles by Ando, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hisada, K.
Right arrow Articles by Ando, A.

Tumor Scanning with 169Yb-Citrate

Kinichi Hisada, Norihisa Tonami, Tatsunosuke Hiraki and Atsushi Ando

Kanazawa University, Kanazawa, Japan

Correspondence: For reprints contact: Kinichi Hisada, Dept. of Nuclear Medicine, School of Medicine, Kanazawa University, 13-1 Takara-machi, Kanazawa-shi, Japan.

ABSTRACT

The results of tumor scanning with 169Yb are presented. Positive scans were obtained in 13 of 15 patients with primary lung and liver cancer or lymphosarcoma and various metastatic lesions of bone. The advantages and disadvantages of 169Yb as a tumor-scanning agent are discussed.

FOOTNOTES

Originally appeared in J Nucl Med 14: 772–773, 1973, without figures.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1974 by the Society of Nuclear Medicine.